UNICA IRIS Institutional Research Information System

DEVOTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 128.799
NA - Nord America 6.509
AS - Asia 750
SA - Sud America 9
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 136.077
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 126.964
US - Stati Uniti d'America 6.493
UA - Ucraina 626
CN - Cina 609
SE - Svezia 488
DE - Germania 227
GB - Regno Unito 201
FI - Finlandia 157
FR - Francia 60
SG - Singapore 53
IN - India 34
VN - Vietnam 22
RU - Federazione Russa 19
BE - Belgio 16
NL - Olanda 16
CA - Canada 14
IR - Iran 10
JP - Giappone 10
PL - Polonia 8
BR - Brasile 7
MU - Mauritius 6
PT - Portogallo 5
TR - Turchia 5
EU - Europa 4
BG - Bulgaria 3
HK - Hong Kong 2
AR - Argentina 1
AT - Austria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
LB - Libano 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 136.077
Salva come PNG Salva come JPEG
Città #
Cagliari 126.596
Fairfield 898
Woodbridge 711
Chandler 618
Houston 547
Ashburn 483
Ann Arbor 418
Seattle 363
Nyköping 336
Jacksonville 334
Wilmington 321
Dearborn 291
Cambridge 277
Nanjing 113
Boardman 111
Boston 84
Beijing 83
San Diego 80
Helsinki 62
Shanghai 58
Shenyang 48
Milan 36
Nanchang 35
Hebei 32
Redwood City 30
Hefei 25
Changsha 22
Dong Ket 22
Tianjin 22
Verona 22
Washington 22
Guangzhou 21
London 21
New York 21
Santa Maria Coghínas 20
Los Angeles 19
Kunming 18
Mountain View 18
Norwalk 18
San Mateo 18
Orange 17
Pune 17
Brussels 16
Jiaxing 16
Jinan 14
Zhengzhou 14
Ningbo 13
Detroit 12
Leawood 12
Toronto 12
Falls Church 11
Auburn Hills 10
Augusta 10
Amsterdam 9
Monmouth Junction 9
San Francisco 8
Sassari 8
Padova 7
Saint Petersburg 7
Ardabil 6
Edinburgh 6
Mumbai 6
Oristano 6
Rome 6
Sarroch 6
Chengdu 5
Kilburn 5
Millbury 5
New Bedfont 5
Xian 5
Arezzo 4
Nürnberg 4
Phoenix 4
Taizhou 4
Torino 4
Alghero 3
Atlanta 3
Bologna 3
Borås 3
Brescia 3
Chicago 3
Florence 3
Fuzhou 3
Hangzhou 3
Shenzhen 3
Siena 3
Sofia 3
Wenzhou 3
Ankara 2
Baotou 2
Bracke 2
Chongqing 2
Hong Kong 2
Horsham 2
Lille 2
Malogoszcz 2
Montijo 2
Nagold 2
Naples 2
Panicale 2
Totale 133.640
Salva come PNG Salva come JPEG
Nome #
Maternal immune activation disrupts dopamine system in the offspring 3.598
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 3.502
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.370
Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex 3.222
null 2.940
The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating 2.934
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 2.783
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 2.719
Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats 2.601
Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress 2.436
Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation 2.426
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.392
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.342
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex 2.314
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.312
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.278
Positive allosteric modulation of GABAB receptors ameliorates sensorimotor gating in rodent models 2.260
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.225
Effects of maternal immune activation on dopamine activity in male and female offspring 2.111
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 2.053
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice 2.032
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 1.965
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex 1.949
null 1.934
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease 1.930
Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats 1.795
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 1.789
The steroid 5-alpha reductases mediate the abnormalities in information processing and attention mechanisms induced by REM sleep deprivation 1.743
null 1.722
Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson's disease 1.718
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.698
Modulation of the Startle Response in REM Sleep Behavior Disorder 1.691
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus 1.681
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 1.607
Reserpine treatment ablates the deficits of sensorimotor gating induced by dopamine D3 receptor activation in Sprague-Dawley, but not Long-Evans rats 1.588
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.570
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechyanisms in nucleus accumbens and prefrontal cortex 1.535
Antipsychotic-like properties of antiandrogenic drugs: focus on dopaminergic system 1.531
5-alpha reductase expression is reduced in brain of isolation-reared rats: relevance to dopaminergic impairments 1.523
Allopregnanolone mediates manic-like outcomes of REM sleep deprivation 1.501
Inhibition of 5α-reductase counters the behavioral effects of D1, but not D2 dopamine receptor activation 1.486
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.422
Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release 1.420
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 1.410
Fasting biases µ-opioid receptors toward β–arrestin2-dependent signaling in the accumbens shell 1.366
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.354
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 1.352
Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex 1.339
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex 1.324
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.305
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechanisms in nucleus accumbens and prefrontal cortex 1.286
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 1.268
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.237
The genetic deletion of monoamine oxidase (MAO) gene promotes autistic-like phenotypes in mice 1.225
EFFECT OF NORADRENERGIC DENERVATION ON CEREBRAL CORTEX CATECHOLAMINES IN THE RAT 1.204
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex 1.167
Effects of post-weaning social isolation on 5-alpha reductase: Relevance to dopaminergic pathway 1.160
Dopamine-beta-hydroxylase inhibition potentiates cocaine effect on dopamine release in the medial prefrontal cortex 1.118
Altered expression level of nucleus accumbens proteins in isolation-reared rats 1.108
Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice 1.094
null 1.078
Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex 1.012
Steroid 5 alpha-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders 895
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis 842
5-alpha reductase inhibitors as a novel therapy for Tourette Syndrome: Clinical Evidence 716
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 693
Detection of 3H-cimetidine specific binding in rat anterior pituitary 668
Thymic oxytocin like immunoreactivity is increased in morphine tolerant dependent rats 623
Disulfiram and diethylditiocarbamate intoxication affects the storage and release of striatal dopamine 586
Biochemical characterization of rat forebrain septum dopaminergic innervation. 578
5-Alpha reductase inhibitors modulate dopaminergic signaling: relevance to psychosis 574
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 557
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants 524
Chronic SCH 23390 produces tolerance to morphine extrapiramidal effects 524
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation 506
null 470
Decreased adenosine A2 receptor function in morphine dependent rats 464
Effect of calcium antagonists on [3H] dopamine uptake 447
Chronic imipramine reduces [3H]SCH 23390 binding and DA sensitive adenylate cyclase in the limbic system 445
Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390 434
Selective adenylate cyclase increase in the limbic area of long term imipramine treated rats 417
Evidence that cortical dopamine is a co-transmitter in noradrenergic neurons 415
On the origin of cortical dopamine: Is it a co-transmitter in noradrenergic neurons? 382
null 381
Opioid activity of lefetamine 370
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study 357
Differential effect of Mu, Delta, and kappa opioid agonists on adenylate cyclase activity 345
Adrenergic sensitive adenylate cyclase in rat posterior pituitary 343
[3H] spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland 343
Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates 338
Possible antidepressant activity of methadone 337
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 336
Dopamine and noradrenaline coupling in the cerebral cortex 333
Opiate k receptors agonists do not inhibit adenylate cyclase activity 322
Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats 318
In utero exposure to methadone produces a stable decrease of the cortex 5-HT transport system in rats 317
Sodium dependent interaction of benzamides with dopamine receptors 317
The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex 301
Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D(2)-like receptor agonist quinpirole 289
Sodium dependent interaction of benzamides with dopamine receptors in rat and dog anterior pituitary glands 286
Totale 132.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.345 0 0 0 0 0 0 0 0 0 0 674 671
2019/202031.423 1.664 973 193 475 11.886 8.201 4.355 963 608 588 624 893
2020/202141.262 1.241 1.545 1.446 11.887 8.560 4.345 3.194 2.456 874 1.958 2.175 1.581
2021/20228.438 914 581 730 497 582 688 581 540 606 765 906 1.048
2022/202311.543 1.070 1.439 1.147 953 994 1.182 651 811 901 800 1.045 550
2023/20249.335 622 500 464 656 1.148 1.638 1.812 737 753 892 113 0
Totale 136.370